Stock Price
6.10
Daily Change
-1.03 -14.45%
Monthly
-19.74%
Yearly
39.59%
Q2 Forecast
5.99

Silence Therapeutics reported $3.73M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 5.06B 455M Mar/2026
Autolus Therapeutics Ltd USD 39.95M 4.16M Mar/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Novartis USD 3.14B 296M Mar/2026
Roche Holding CHF 7.28B 3.99B Dec/2025
Silence Therapeutics USD 3.73M 2.06M Dec/2025